Atlas Trials

A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Clinical trial NCT00504192 · COMPLETED

Trial details

NCT number
NCT00504192
Sponsor
Soonchunhyang University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract AdenocarcinomaGemcitabineOxaliplatinCombination ChemotherapyEfficacy
Start date
2006-09-01
Primary completion
2008-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.